|
[Related PubMed/MEDLINE]
Total Number of Papers: 4783
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: AGEs |
| Long Form |
: advanced glycation end products |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
2'-Deoxyribose mediated glycation leads to alterations in BSA structure via generation of carbonyl species. |
BSA, RCS |
| 2 |
2020 |
2,5-diketopiperazines mitigate the amount of advanced glycation end products accumulated with age in human dermal fibroblasts. |
DKPs |
| 3 |
2020 |
A Bibenzyl Component Moscatilin Mitigates Glycation-Mediated Damages in an SH-SY5Y Cell Model of Neurodegenerative Diseases through AMPK Activation and RAGE/NF-kappaB Pathway Suppression. |
AMPK |
| 4 |
2020 |
A biochemical & biophysical study on in-vitro anti-glycating potential of iridin against d-Ribose modified BSA. |
ANS, BSA, CC, CR, EGPs, Gly-BSA, HMF, ID, ThT |
| 5 |
2020 |
A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNalpha + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress. |
CHC, GT, HCV, IFN-alpha, IR, OS, SOD |
| 6 |
2020 |
A New Italian Purple Corn Variety (Moradyn) Byproduct Extract: Antiglycative and Hypoglycemic In Vitro Activities and Preliminary Bioaccessibility Studies. |
--- |
| 7 |
2020 |
A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort). |
AU, CI, PA, SAF, SQUASH |
| 8 |
2020 |
A unifying model of glucotoxicity in human renal proximal tubular epithelial cells and the effect of the SGLT2 inhibitor dapagliflozin. |
GAPDH, IL-8, O-GlcNAc, PKC, ROS, RPTECs, SGLT2, TGF-beta1 |
| 9 |
2020 |
Accelerated Kidney Aging in Diabetes Mellitus. |
DM, DN |
| 10 |
2020 |
Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes. |
HFD-induced, RAGE, T2D |
| 11 |
2020 |
Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. |
AS, AVA, DM, IL-6, RAGE, ROS, sRAGE |
| 12 |
2020 |
Accumulation rate of advanced glycation end products in recent onset psychosis: A longitudinal study. |
--- |
| 13 |
2020 |
Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study. |
--- |
| 14 |
2020 |
Activation of GPR40 Suppresses AGE-Induced Reduction of Type II Collagen and Aggrecan in Human SW1353 Chondrocytes. |
ECM, OA |
| 15 |
2020 |
Activation of Notch1 signaling in podocytes by glucose-derived AGEs contributes to proteinuria. |
DN, EMT, RAGE |
| 16 |
2020 |
Advanced Glycation End Product Accumulation in Subjects with Open-Angle Glaucoma with and without Exfoliation. |
EG, PG, SAF |
| 17 |
2020 |
Advanced Glycation End Product Accumulation is Associated with Lower Cognitive Performance in an Older General Population: The Nagahama Study. |
--- |
| 18 |
2020 |
Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort. |
CERAD, ELISA |
| 19 |
2020 |
Advanced Glycation End Product Inhibition by Alkaloids from Ocotea paranapiacabensis for the Prevention of Skin Aging. |
ADME |
| 20 |
2020 |
Advanced glycation end products (AGEs) synergistically potentiated the proinflammatory action of lipopolysaccharide (LPS) and high mobility group box-1 (HMGB1) through their direct interactions. |
HMGB1, LPS, TNF |
| 21 |
2020 |
Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects. |
--- |
| 22 |
2020 |
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation. |
ALL, CV, GVHD, HSCT, TBI |
| 23 |
2020 |
Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease. |
NDD, PC, PD |
| 24 |
2020 |
Advanced Glycation End Products and Receptor (RAGE) Promote Wound Healing of Human Corneal Epithelial Cells. |
HCE, NF, RAGE |
| 25 |
2020 |
Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis. |
alpha-SMA, PD |
| 26 |
2020 |
Advanced glycation end products derived from serum albumin modification by glucose (AGE-1) reflect clustering of lipid-associated metabolic abnormalities and are decreased in patients treated with acarbose: A cross-sectional study. |
CRP, HDL, MetS, NAFLD |
| 27 |
2020 |
Advanced Glycation End Products Enhance Biofilm Formation by Promoting Extracellular DNA Release Through sigB Upregulation in Staphylococcus aureus. |
DFI, DFU, eDNA |
| 28 |
2020 |
Advanced glycation end products enhance M1 macrophage polarization by activating the MAPK pathway. |
GSIS, T2DM |
| 29 |
2020 |
Advanced glycation end products enhance macrophage polarization to the M1 phenotype via the HIF-1alpha/PDK4 pathway. |
BSA, HIF-1alpha, PDK4 |
| 30 |
2020 |
Advanced glycation end products facilitate the proliferation and reduce early apoptosis of cardiac microvascular endothelial cells via PKCbeta signaling pathway: Insight from diabetic cardiomyopathy. |
CCK-8, CMECs, FITC, p-ERK, PI, PKC, PMA, RAGE |
| 31 |
2020 |
Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review. |
--- |
| 32 |
2020 |
Advanced glycation end products in diabetes, cancer and phytochemical therapy. |
MG, NF, PI3K, RAGE |
| 33 |
2020 |
Advanced glycation end products in musculoskeletal system and disorders. |
RAGE |
| 34 |
2020 |
Advanced glycation end products increased placental vascular permeability of human BeWo cells via RAGE/NF-kB signaling pathway. |
TEER |
| 35 |
2020 |
Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models. |
AGE, PDR, RAGE, ROCK |
| 36 |
2020 |
Advanced Glycation End Products Induce Proliferation and Migration of Human Aortic Smooth Muscle Cells through PI3K/AKT Pathway. |
F-actin, HASMCs, RAGE, VSMCs |
| 37 |
2020 |
Advanced glycation end products induce proliferation, invasion and epithelial-mesenchymal transition of human SW480 colon cancer cells through the PI3K/AKT signaling pathway. |
E-cadherin, EMT |
| 38 |
2020 |
Advanced Glycation End Products Induce Vascular Smooth Muscle Cell-Derived Foam Cell Formation and Transdifferentiate to a Macrophage-Like State. |
ACTA2, CML, ELISA |
| 39 |
2020 |
Advanced glycation end products inhibit neural stem cell differentiation via upregualtion of HDAC3 expression. |
DACD, DM, NSCs |
| 40 |
2020 |
Advanced glycation end products inhibit the osteogenic differentiation potential of adipose-derived stem cells by modulating Wnt/beta-catenin signalling pathway via DNA methylation. |
5-aza-dC, ASCs |
| 41 |
2020 |
Advanced glycation end products reduce macrophage-mediated killing of Staphylococcus aureus by ARL8 upregulation and inhibition of autolysosome formation. |
--- |
| 42 |
2020 |
Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease. |
--- |
| 43 |
2020 |
Advanced glycation end-products (AGE) trapping agents: Design and synthesis of nature inspired indeno[2,1-c]pyridinones. |
AGE |
| 44 |
2020 |
Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes. |
AOPP, FRAP |
| 45 |
2020 |
Advanced glycation end-products disrupt brain microvascular endothelial cell barrier: The role of mitochondria and oxidative stress. |
BBB, BSA, BSA |
| 46 |
2020 |
Advanced glycation end-products increase lipocalin 2 expression in human oral epithelial cells. |
dHL-60, DM, IL-6, LCN2, PgLPS |
| 47 |
2020 |
Advanced glycation end-products suppress autophagy by AMPK/mTOR signaling pathway to promote vascular calcification. |
BSA, TEM, VSMC |
| 48 |
2020 |
Advanced glycosylation end products (AGEs) controls proliferation, invasion and permeability through orchestrating ARHGAP18/RhoA pathway in human umbilical vein endothelial cells. |
CCK-8, HUVECs |
| 49 |
2020 |
Age-dependent altered redox homeostasis in the chronodisrupted rat model and moderation by melatonin administration. |
AChE, ALAN, AOPP, CD, FRAP, MDA, MLT, PCO, PMRS, ROS, SA |
| 50 |
2020 |
AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3. |
DKD, DM, EZH2 |
| 51 |
2020 |
AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment. |
CLLI |
| 52 |
2020 |
AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment. |
AF |
| 53 |
2020 |
AGE-RAGEsynergy influences programmed cell death signaling to promote cancer. |
--- |
| 54 |
2020 |
Age-related shifts in gut microbiota contribute to cognitive decline in aged rats. |
BDNF, FMT, RAGE |
| 55 |
2020 |
AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy. |
ER, ncRNAs, RAGE, ROS |
| 56 |
2020 |
AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes. |
NASH |
| 57 |
2020 |
AGEs-RAGE axis causes endothelial-to-mesenchymal transition in early calcific aortic valve disease via TGF-beta1 and BMPR2 signaling. |
ALP, alpha-SMA, CAVD, EndMT, TGF-beta1, VE-cadherin |
| 58 |
2020 |
Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-kappaB signaling pathways in C57BL/6 mice. |
BUN, CAT, Cr, DN, FBG, HDL-C, HFD, INS, LDL-C, MDA, SOD, STZ, T2D, TC, TG |
| 59 |
2020 |
Allithiamine Alleviates Hyperglycaemia-Induced Endothelial Dysfunction. |
HUVECs |
| 60 |
2020 |
alpha-Bisabolol suppresses the inflammatory response and ECM catabolism in advanced glycation end products-treated chondrocytes and attenuates murine osteoarthritis. |
BISA, DMM, ECM, JNK, NF-kappaB, OA |
| 61 |
2020 |
Altered Mineral Metabolism and Disequilibrium Between Calcification Promoters and Inhibitors in Chronic Hemodialysis Patients. |
CRP, FGF23, HD, MDA, MGP, Se, Zn |
| 62 |
2020 |
Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies. |
DM, HAP1 |
| 63 |
2020 |
An Electrochemical Chip to Monitor In Vitro Glycation of Proteins and Screening of Antiglycation Potential of Drugs. |
--- |
| 64 |
2020 |
An invitro approach to unveil the structural alterations in d-ribose induced glycated fibrinogen. |
NEPTM |
| 65 |
2020 |
An update on the potential role of advanced glycation end products in glycolipid metabolism. |
--- |
| 66 |
2020 |
Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS. |
CHOP, ER, GLCs, PCOS, RAGE, TUDCA |
| 67 |
2020 |
Antagonism of GPR4 with NE 52-QQ57 and the Suppression of AGE-Induced Degradation of Type II Collagen in Human Chondrocytes. |
COX2, IL, iNOS, MMP, NF-kappaB, NO, OA, PGE2, TNF-alpha |
| 68 |
2020 |
Anti-glycation effect and the alpha-amylase, lipase, and alpha-glycosidase inhibition properties of a polyphenolic fraction derived from citrus wastes. |
--- |
| 69 |
2020 |
Anti-Opioid Antibodies in Individuals Using Chronic Opioid Therapy for Lower Back Pain. |
ELISA, OUD |
| 70 |
2020 |
Antiglycation Activities and Common Mechanisms Mediating Vasculoprotective Effect of Quercetin and Chrysin in Metabolic Syndrome. |
CH, DPPH, MetS, MG |
| 71 |
2020 |
Antioxidant and Antiglycation Activities of Syzygium paniculatum Gaertn and Inhibition of Digestive Enzymes Relevant to Type 2 Diabetes Mellitus. |
--- |
| 72 |
2020 |
Antioxidative and Angiogenesis-Promoting Effects of Tetrahedral Framework Nucleic Acids in Diabetic Wound Healing with Activation of the Akt/Nrf2/HO-1 Pathway. |
HO-1, HUVECs, NO, Nrf2, ROS, tFNAs, VEGF-A |
| 73 |
2020 |
Antirhea borbonica Aqueous Extract Protects Albumin and Erythrocytes from Glycoxidative Damages. |
Ab, MGO |
| 74 |
2020 |
APOE epsilon4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism. |
G82S, sRAGE |
| 75 |
2020 |
Application of a Pseudotargeted MS Method for the Quantification of Glycated Hemoglobin for the Improved Diagnosis of Diabetes Mellitus. |
DDA, iRT, PRM, T2DM |
| 76 |
2020 |
Are Finger Skin Fluorophores Other Than Advanced Glycation End Products (AGEs) Associated With Impaired Musculoskeletal Properties? |
--- |
| 77 |
2020 |
Assessment of advanced glycation end products in the peri-implant sulcular fluid among moderate cigarette-smokers and nonsmokers with peri-implantitis. |
CBL, GI, PD, PI, PISF |
| 78 |
2020 |
Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study. |
HR |
| 79 |
2020 |
Association between the tissue accumulation of advanced glycation end products and exercise capacity in cardiac rehabilitation patients. |
CR, CVD, DM, SAF |
| 80 |
2020 |
Association of physical fitness with skin autofluorescence-derived advanced glycation end products in children. |
BMI, BP, CRF |
| 81 |
2020 |
Awakening cortisol indicators, advanced glycation end products, stress perception, depression and anxiety in parents of children with chronic conditions. |
ASD, CG, CP, DMT1, DS |
| 82 |
2020 |
Beneficial Effect of Mildly Pasteurized Whey Protein on Intestinal Integrity and Innate Defense in Preterm and Near-Term Piglets. |
EH-WPC, IMF, MP-WPC |
| 83 |
2020 |
Beta carotene protects H9c2 cardiomyocytes from advanced glycation end product-induced endoplasmic reticulum stress, apoptosis, and autophagy via the PI3K/Akt/mTOR signaling pathway. |
ATF4, Bax, BC, Bcl-2, CHOP, cTnI, DCM, ELISA, ER, GRP78, GSH-Px, LC3, LDH, MDA, p-AKT, p-mTOR, p-PI3K, ROS, SOD |
| 84 |
2020 |
Binding of CML-Modified as Well as Heat-Glycated beta-lactoglobulin to Receptors for AGEs Is Determined by Charge and Hydrophobicity. |
CML |
| 85 |
2020 |
Bombax ceiba (Linn.) calyxes ameliorate methylglyoxal-induced oxidative stress via modulation of RAGE expression: identification of active phytometabolites by GC-MS analysis. |
BCCE, GC-MS, GLO1, MG, NOX, ROS |
| 86 |
2020 |
Bradykinin and oxidative stress in patients with hereditary angioedema due to C1 inhibitor deficiency. |
AOPPs, C1-INH, HAE, PBMCs, ROS |
| 87 |
2020 |
Can advanced glycation end-products and their receptors be affected by weight loss? A systematic review. |
esRAGE, sRAGE |
| 88 |
2020 |
Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps? |
CRSwNP, EMT, ERK, MAPKs, NP, RAGE |
| 89 |
2020 |
Casein Hydrolysate Containing Milk-Derived Peptides Reduces Facial Pigmentation Partly by Decreasing Advanced Glycation End Products in the Skin: A Randomized Double-Blind Placebo-Controlled Trial. |
baPWV |
| 90 |
2020 |
Cellular and Molecular Aspects of Blood Cell-Endothelium Interactions in Vascular Disorders. |
GP, ICAM, PV, RBCs, RVO, VCAM |
| 91 |
2020 |
Characterization of the acidic species of a monoclonal antibody using free flow electrophoresis fractionation and mass spectrometry. |
FFE, icIEF |
| 92 |
2020 |
Chemical screening identifies an extract from marine Pseudomonas sp.-PTR-08 as an anti-aging agent that promotes fission yeast longevity by modulating the Pap1-ctt1+ pathway and the cell cycle. |
ROS |
| 93 |
2020 |
Circulating antibodies against age-modified proteins in patients with coronary atherosclerosis. |
BSA, CABG, CAD |
| 94 |
2020 |
Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes. |
BMI, GLP-1, i.v, OGTT, sRAGE |
| 95 |
2020 |
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study. |
CHD, CTCA, RAGE |
| 96 |
2020 |
Comparative study of different glycating agents on human plasma and vascular cells. |
--- |
| 97 |
2020 |
Comparison Between Biomarkers of Kidney Injury, Inflammation, and Oxidative Stress in Patients with Diabetic Nephropathy and Type 2 Diabetes Mellitus. |
DN, MMP-2, T2DM, TNF-alpha |
| 98 |
2020 |
Comparison between Standard Single Chamber vs Dual Chamber Low Glucose Degradation Product Peritoneal Dialysis Fluids. |
DC, ECW/TBW, GDPs, PD, SAF |
| 99 |
2020 |
Comparison of glucose degradation product and receptor levels in dabetic and normal pregnancy. |
BMI, CML |
| 100 |
2020 |
Comparison of skin autofluorescence, a marker of tissue advanced glycation end-products in the fistula and non-fistula arms of patients treated by hemodialysis. |
AVF, HD, SAF |
|
A Search Service for Abbreviation / Long Form
